
The therascreen KRAS RGQ PCR Kit is a companion diagnostic test for use as an aid in identifying patients with non-small cell lung cancer (NSCLC) for whom treatment with LUMAKRAS (sotorasib) or KRAZATI (adagrasib) may be appropriate. The kit is a qualitative assay that can deliver results in less than two working days.
To find a lab that provides testing using the therascreen KRAS RGQ PCR Kit, please see the list of labs below and keep in mind this resource:
- Is updated frequently, so continue to check back regularly for the most up-to-date information
- May not represent all of the labs that offer testing using the therascreen KRAS RGQ PCR Kit
- May not represent each location of the labs below, contact the lab of interest to find the nearest location
If you are a lab that offers the therascreen KRAS RGQ PCR test and don’t see your lab listed below, please contact your QIAGEN sales representative or contact QIAGEN at 800-426-8157, option 1.
Labs that provide testing of clinical NSCLC tumor tissue using the therascreen KRAS RGQ PCR Kit
Laboratory Corporation of America Holdings
Labcorp Oncology
IU Health Pathology Laboratory
Oncocyte
Pathology Associates
QIAGEN has a broad portfolio of companion diagnostic products in development.
The therascreen KRAS RGQ PCR Kit is for in vitro diagnostic use.